Background/Objectives: Vitamin A deficiency (VAD) is a major public health problem. The supplementation of lactating women could be an effective strategy to combat it. The objective of this study was to assess the impact of maternal vitamin A supplementation on the mother-infant pair. Subjects/Methods: This was a double blind, placebo-controlled randomized clinical assay in which 33 women received 200 000 IU of vitamin A and 33 women received soy oil between 20th and 30th postpartum days. Maternal blood and milk samples were collected immediately before supplementation and 3 months after delivery, when blood was also collected from the babies. Retinol concentrations p0.70 mmol/l in serum and 1.05 mmol/l in milk were considered to indicate VAD. Results: Increase in serum retinol level was observed in the supplemented group compared with the pre-supplementation levels (1.05 and 1.17 mmol/l, respectively; P ¼ 0.026) and to the post-supplementation levels of the control group (1.02 mmol/l; P ¼ 0.032). Reduction in breast milk retinol was observed in the control group compared with the pre-supplementation levels (1.93 and 1.34 mmol/l, respectively; Po0.0001) and to the post-supplementation levels of the supplemented group (1.56 mmol/l; P ¼ 0.0003). There was significant difference in the prevalence of VAD in breast milk after supplementation, 55.6% (15/27) in the control group and 16.1% (5/31) in the supplemented group (P ¼ 0.002). VAD was present in 66.1% (39/59) of infants, with mean serum retinol levels of 0.64 ± 0.30 mmol/l in the control group and of 0.69 ± 0.26 mmol/l in the supplemented group. Conclusions: Supplementation had a positive impact on maternal vitamin A status. No effect on infant status was detectable 2 months after supplementation with a single dose.
Introduction
Vitamin A deficiency (VAD) is a public health problem in many regions of the world, especially in developing countries, affecting approximately 7.2 million pregnant women and 127 million children of preschool age (West, 2002) . In Mexico, a Latin-American country, the prevalence of VAD among women and children ranges from 0 to 25% (Casanueva et al., 1999; Villalpando et al., 2003; García-Guerra et al., 2009) .
In Brazil, a National Survey of Demography and Health (PNDS 2006 ) revealed a 17.4% prevalence of VAD among children aged 6-59 months and a 12.3% prevalence among women (Brasil, 2009) . Studies conducted over the past decade in Ribeirão Preto, state of São Paulo, have indicated a high prevalence of VAD among infants, preschoolers and schoolchildren (Ferraz et al., 2000 (Ferraz et al., , 2004 Custódio et al., 2009) .
In developing countries, mothers usually have VAD because they consume diets with low vitamin A content and they experience high fertility with prolonged breastfeeding. Infants acquire VAD due to three reasons: their mothers are deficient and produce milk poor in vitamin A; they are weaned and receive diets offering little vitamin A and they spend a substantial part of infancy being sick, with anorexia, malabsorption and increased catabolism, with consequent further deterioration of their vitamin A levels (Miller et al., 2002) .
VAD can cause multiple dysfunctions, such as ocular abnormalities, epithelial metaplasia and immunological dysfunction, increasing the risk of respiratory and diarrheic diseases, with a consequent increase in morbidity and mortality (Cameron et al., 2008; Sommer, 2008) .
Interventions have been proposed over the past years and supplementation of lactating mothers is recommended by the World Health Organization (WHO) in all regions affected with VAD (Ross, 2002; Tanumihardjo, 2004) as a strategy for the improvement of the vitamin A status of mothers and babies (Allen, 2005) .
Maternal vitamin A supplementation has many advantages for the baby, as it provides adequate amounts of vitamin A on a daily basis through mother's milk, thus being considered the safest form of supplying this vitamin to newborn babies (Basu et al., 2003) .
Thus, the objective of this study was to assess the impact of maternal supplementation with a single dose of retinyl palmitate on the vitamin A status of mother, breast milk and infant.
Subjects and methods
This was a randomized double-blind, placebo-controlled clinical assay conducted on mothers and their babies from a community at the periphery of Ribeirão Preto (Brazil) attended at a Basic Health Unit over a period of 1 year (September 2006 to September 2007 . The mean per capita income of the families was approximately 120 dollars a month (Ferraz et al., 2004) and they had easy access to health services, with complete vaccination coverage. Most of them lived in brick houses with piped water, sewage service and electricity.
All the pregnant women attended at the outpatient clinic during this period were invited to participate in the study. Inclusion criteria were age X18 years, exclusive breastfeeding at the beginning of the study, singleton newborns, gestational age of 37-41 weeks, weight at birth X2500 g, with no congenital malformations. Both mother and child were supposed to be in good health, with no untoward events during the peripartum period, and the mothers were not supposed to use medications or vitamin supplements during lactation. Thus, 66 mother-infant pairs were included in the study and assigned at random to two groups: supplemented group consisting of 33 mothers who received a single dose of 200 000IU vitamin A (retinyl palmitate) between the 20 and 30th days after delivery, and placebo group consisting of 33 mothers who received identical capsules containing soy oil during the same interval. They were followed up for about 2 months. Five of them did not complete the study, four because they refused to remain in the study and one due to the death of the baby. Also, the parents of two babies did not permit us to collect blood from their children. Thus, 61 mothers and 59 babies completed the study (Figure 1) .
Maternal blood and milk samples were collected immediately before (T0) and after (T1) supplementation (3 months after delivery). Blood was collected from the babies at 3 months of age. For the evaluation of serum retinol, 4 ml venous blood from the mothers and 2 ml from the babies was collected into Vacutainer tubes (BD, Becton Drive, Franklin Lakes, NJ, USA) and carried to the laboratory under protection from light where the serum obtained was separated by centrifugation and frozen at À70 1C until the analysis. Breast milk samples (5 ml) were collected between 0730 and 0900 hours by manual expression, with no Vitamin A supplementation on mother-infant pair TM Martins et al preference for one breast, into tubes protected from light, carried to the laboratory and frozen at À70 1C until the analysis. Serum and milk retinol was determined by highpressure liquid chromatography, according to the procedures proposed by Arnaud et al. (1991) and Strobel et al. (2000) . A model LC9 Shimadzu (Nishinokyo-Kuwabara-cho, Nakagyo-ku, Kyoto, Japan) apparatus with a 25 Â 0.46 cm C18 column (ODS), UV/Vis detector (SPD-6AV), SCL-6B controller and C-R6A register calibrated for retinol measurement at 325 nm wavelength was used. The flow of the mobile phase was fixed at 2 ml/min. All-trans-retinol (Sigma Chemical, St Louis, MO, USA) was used as an external standard. The detection limit of the method was 0.016 mmol/l. Retinol concentrations p0.70 mmol/l in serum and p1.05 mmol/l in milk were considered to be deficient (World Health Organization, 1996) . The concentration of C-reactive protein (CRP) was determined by turbidimetry (Winkles et al., 1987; Ledue et al., 1989) and was used as a laboratory indicator of infection/ inflammation, with concentrations X1.0 mg per 100 ml being considered abnormal (Macy et al., 1997) . Weight and height were measured according to the methods recommended by the World Health Organization (1995). Body mass index and weight-for-age percentiles (W/A) were used for anthropometric analysis according to the WHO (1998) and the Centers for Disease Control and Prevention (2000) . Sociodemographic and clinical data were obtained by interviewing the mothers. The following data were collected using a questionnaire filled out by the investigator: monthly per capita family income, number of persons residing in the household, parents' schooling, weight (measured with an electronic digital scale with 100 g precision) and height (measured with a wood anthropometer with 0.1 cm precision), a febrile and/or diarrheic episode during the preceding 15 days, parity (number of children), duration of pregnancy, baby's weight and length at birth (collected from the baby's medical records) and at 3 months of life (weight measured with an electronic digital pediatric scale with 5 g precision and length measured with a horizontal pediatric anthropometer with 0.1 cm precision).
The study was approved by the research ethics committee of the University Hospital of Ribeirão Preto-University of São Paulo, and written informed consent was obtained from all the participants.
Data analysis was based on intent to treat because the mothers who interrupted exclusive breast-feeding were not excluded.
Statistical analysis
After exploratory analysis of the data, a mixed-effect model (Schall, 1991; Littell et al., 1996) was used to determine possible differences between groups at each time point and between times within each group, as determined on the basis of maternal serum and milk retinol. In addition, the initial values of the variables were used as a control variable in the model. When the association of the response variable with the group Â time interaction was detected, orthogonal contrasts were estimated to determine differences between means. The PROC MIXED procedure of the SAS software version 9 (SAS Institute Inc., 2002) was used. For the infants, serum retinol concentrations were compared between groups by Student's t-test for independent samples. The same test was used to compare groups at the beginning of the study regarding their initial characteristics.
The prevalence of VAD was compared between the groups and the time points studied by Fisher's exact test. Correlations between variables were determined by Pearson's correlation coefficient.
The level of significance was set at 0.05 (5%) in all analyses.
Results

Initial characteristics of the population
At the beginning of the study, no differences were observed between groups (Table 1) . VAD was present in 6.7% (2/30) of the placebo and 6.5% (2/31) of the supplemented group (P ¼ 1.0). Deficient vitamin A levels were observed in 7.4% (2/27) of the breast milk samples from the placebo and 22.6% (7/31) from the supplemented group (P ¼ 0.15).
Anthropometric data
Only one lactating mother had low weight and 98.4% (60/61) were of adequate weight or overweight at both times of evaluation. At 3 months of age, 91.5% (54/59) of the infants were in an adequate nutritional status, 1.7% (1/59) was at nutritional risk and 6.8% (4/59) presented risk of overweight.
C-reactive protein
All infants had CRP values o1.0 mg per 100 ml, without correlation to serum retinol. Among the mothers, 22% (13/59) and 2% (1/60) presented CRP levels X1.0 mg per 100 ml before and after intervention, respectively. CRP levels were not measured because of insufficient blood in two mothers before intervention and in one mother after intervention. There was neither any difference in CRP levels between groups, nor correlation between CRP and serum retinol.
Effect of supplementation on maternal serum retinol In the placebo group, mean serum retinol concentration was 1.04 ± 0.29 and 1.02 ± 0.28 mmol/l before and after intervention, respectively (P ¼ 0.664). The prevalence of VAD was 6.7% (2/30) before and 16.7% (5/30) after (P ¼ 0.424) the intervention. In the supplemented group, mean retinol concentration before and after supplementation was 1.05±0.31 and 1.17±0.34 mmol/l, respectively (P ¼ 0.026) and VAD prevalence was 6.5% (2/31) before and 3.2% (1/31) after (P ¼ 1.000). There was a significant difference in retinol serum levels between groups after intervention (P ¼ 0.032). The proportion of maternal VAD tended to be higher in the placebo group (16.7%) than in the supplemented (3.2%) (P ¼ 0.103) after intervention.
Effect of supplementation on breast milk retinol
At the end of the study, 75.4% (46/61) of the infants continue to be exclusively breast-fed, 19.7% (12/61) received mixed breast-feeding and 4.9% (3/61) were receiving infant formula or cow milk at the time of final data collection. It was not possible to collect breast milk samples from three mothers of babies receiving artificial feeding-all in the placebo group-due to insufficient amount.
In the placebo group, there was a significant difference in mean retinol concentrations in breast milk before and after supplementation (1.93 ± 0.78 and 1.34 ± 0.89 mmol/l, respectively; Po0.0001); in addition, the prevalence of VAD in this group also differed significantly before and after supplementation (7.4%, (2/27) and 55.6% (15/27), respectively; P ¼ 0.0003). No significant differences in retinol levels were observed in the supplemented group before and after intervention (1.75 ± 0.80 and 1.56 ± 0.57 mmol/l, respectively), or in the prevalence of VAD (22.6% (7/31) and 16.1% (5/31)). There was a significant difference in VAD prevalence between groups after supplementation (55.6 and 16.1%, P ¼ 0.002), and in mean retinol values (1.34±0.89 and 1.56±0.57 mmol/l; P ¼ 0.0003). Significantly less marked falls in retinol levels were observed in the milk of supplemented mothers compared with the placebo group (0.19±0.74 and 0.64±1.02 mmol/l; P ¼ 0.029). Table 2 provides an exploratory analysis of the data.
Effect of supplementation on serum retinol levels of the infants At 3 months of age, 66.1% (39/59) of the infants presented serum retinol concentrations p0.70 mmol/l; 61% (36/59) between 0.35 and 0.70 mmol/l and 5.1% (3/59) o0.35 mmol/l.
Of the remaining 33.9% (20/59), 23.7% (14/59) presented serum retinol concentrations between 0.70 and 1.05 mmol/l and 10.2% (6/59) values 41.05 mmol/l. Mean serum retinol concentration was 0.64±0.30 mmol/l in the placebo group and 0.69 ± 0.26 mmol/l in the supplemented group (P ¼ 0.458). The prevalence of VAD was 69.0% (20/29) in the placebo group and 63.3% (19/30) in the supplemented group (P ¼ 0.785). Among infants exclusively breast-fed up to 3 months of age, the prevalence of VAD was 67.4% (31/46) and mean retinol concentration was 0.63±0.25 mmol/l, whereas infants receiving mixed feeding (breast milk þ formula) or exclusively artificial feeding had a VAD prevalence of 57.1% (8/14) and a mean retinol concentration of 0.77±0.35 mmol/l (P ¼ 0.532 for the prevalences and P ¼ 0.120 for the means). VAD was present in 59.1% of the boys (13/22) and in 70.3% of the girls (26/37; P ¼ 0.413).
Discussion
In this study, vitamin A supplementation at the end of the first month after childbirth caused a significant increase in Considered as the sum of wages and other earnings of all residents in the house, in Reais (R$) converted to 'minimum wages' (a value determined by the Brazilian government, in Reais too), divided by the number of persons living at home.
Vitamin A supplementation on mother-infant pair TM Martins et al the serum retinol levels of supplemented mothers by 3 months after delivery. In Indonesia, mothers who received 300 000 IU vitamin A within 1-3 weeks after delivery presented significantly higher mean serum retinol levels compared with the placebo group at 3 months after delivery, that is, 1.39±0.49 and 1.24 ± 0.43 mmol/l, in addition to a lower VAD prevalence, 21 and 33%, respectively (Stoltzfus et al., 1993) . Two studies conducted in Bangladesh (Roy et al., 1997; Rice et al., 1999) also observed a significant increase in serum retinol levels 3 months after delivery in mothers supplemented with 200 000 IU vitamin A compared with the placebo group. In the study by Roy et al. (1997) supplementation was administered 24 h after delivery and in the study by Rice et al. (1999) supplementation was administered 1-3 weeks after delivery. However, in contrast to the present study in which we observed that vitamin A supplementation prevented a significant fall in breast milk retinol levels at 3 months after delivery, the three cited studies observed an increase in breast milk retinol levels at the same time point. Food surveys carried out to determine the frequency of consumption of foods rich in vitamin A and to obtain information about other risk factors such as infections may help explain this phenomenon as the population studied in this investigation does not seem to differ much in socioeconomic terms from the populations studied in the three cited studies, that is, low-income and lowschooling women living in a peripheral region under precarious socioeconomic conditions. The proportions of breast milk samples with VAD and the mean retinol concentrations were significantly different between groups after intervention. Similar results were observed by Rice et al. (1999) in Bangladeshi mothers and by Vinutha et al. (2000) in Indian mothers. The absence of supplementation and the low intake of foods rich in vitamin A, as well as the increased metabolic demand during lactation, may explain the high percentage of reduced retinol concentrations in the milk of mothers of the placebo group.
In this study, no effect on the infants' vitamin A status was detectable 2 months after maternal supplementation. In India, Bhaskaram et al. (2000) also did not observe differences in the serum retinol levels between a group of 3-month-old infants whose mothers had received 200 000 IU vitamin A soon after delivery and a placebo group. In Bangladesh, Rice et al. (1999) observed that 6-month-old infants whose mothers had received 200 000 IU vitamin A 1-3 weeks after delivery presented higher serum retinol levels than the placebo group. However, 87% of them presented an inadequate modified relative dose response.
However, other authors have observed benefits of maternal vitamin A supplementation for the infant. Stoltzfus et al. (1993) observed higher serum retinol levels and fewer inadequate RDR in 6-month-old infants whose mothers had received 300 000 IU vitamin A 1-3 weeks after delivery compared with controls. In two Indian studies (Vinutha et al., 2000; Basu et al., 2003) , significantly higher serum retinol levels were observed in 3-month-old infants whose mothers were supplemented with 200 000 IU vitamin A immediately after delivery compared with the placebo group. It is difficult to explain these differences in relation to our findings simply on the basis of socioeconomic conditions as all the cited studies were conducted on lowincome populations. However, factors related to both mothers and infants, such as infections, parasitic infestations and access to foods rich in vitamin A, may explain the differences observed.
The serum retinol concentrations of the babies studied here were low in both groups. Similar observations were made in a study conducted in Indonesia (Schmidt et al., 2001) , in which 470% of the infants presented serum retinol levels o0.70 mmol/l at 4 months of age. Some investigators have questioned the use of 0.70 mmol/l as the cutoff point indicating the presence of VAD in young infants (Lindblad et al., 1998; Bhaskaram et al., 2000; Schmidt et al., 2001, de Pee and Dary, 2002) , and have proposed a value of 0.35 mmol/l as the limit (Lindblad et al., 1998) . It is known that babies are born with low hepatic reserves of vitamin A, showing retinol levels up to 50% lower than those of their mothers (Olson et al., 1984; Haskell and Brown, 1999; Azais-Braesco and Pascal, 2000) . In addition, owing to immaturity of the gastrointestinal tract, vitamin A absorption may be less efficient in infants younger than 6 months than in adults and circulating retinol levels p0.70 mmol/l are common, even in well-nourished populations (Haskell and Brown, 1999) . Thus, these observations can help explain the high percentage of serum retinol levels o0.70 mmol/l in young infants observed in various studies.
Another possible explanation for the VAD in the infants may be the concentration of retinol in breast milk. In this study, even after supplementation, 34.5% (20/58) of the mothers studied presented levels still considered to be deficient.
Another question to be considered is the possible benefit for the serum retinol levels of newborn infants during the first weeks after maternal supplementation, as in this study the infants' serum retinol was determined only once, about 2 months after the intervention. Thus, the lack of information about serum vitamin A concentration during the period from supplementation to 3 months of age is a limitation of this study, as the initial status and the course of vitamin A levels are unknown. Two implications derive from these observations: (1) a prospective follow-up of cases with normal or elevated initial values does not follow the same pattern as that of cases who present lower values already at point zero, and (2) the initial evaluation would permit the distinction of the temporal evolution of retinol levels between the infant's blood and maternal blood. Another limitation is the lack of data about food consumption, which, if available, might have helped explain the results.
In conclusion, supplementation of women with 200 000 IU vitamin A by the oral route for a period of 20-30 days after delivery was found to have a positive impact on maternal vitamin A status, but no effect on infant status was detectable 2 months after maternal supplementation.
